GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (TSE:4523) » Definitions » Cyclically Adjusted PS Ratio

Eisai Co (TSE:4523) Cyclically Adjusted PS Ratio : 0.90 (As of May. 24, 2024)


View and export this data going back to 1961. Start your Free Trial

What is Eisai Co Cyclically Adjusted PS Ratio?

As of today (2024-05-24), Eisai Co's current share price is 円6640.00. Eisai Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was 円7,369.71. Eisai Co's Cyclically Adjusted PS Ratio for today is 0.90.

The historical rank and industry rank for Eisai Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

TSE:4523' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.64   Med: 0.91   Max: 1.54
Current: 0.9

During the past years, Eisai Co's highest Cyclically Adjusted PS Ratio was 1.54. The lowest was 0.64. And the median was 0.91.

TSE:4523's Cyclically Adjusted PS Ratio is ranked better than
74.19% of 744 companies
in the Drug Manufacturers industry
Industry Median: 2.12 vs TSE:4523: 0.90

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Eisai Co's adjusted revenue per share data for the three months ended in Mar. 2024 was 円664.242. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is 円7,369.71 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Eisai Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Eisai Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eisai Co Cyclically Adjusted PS Ratio Chart

Eisai Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.98 0.95 0.75 0.98 0.84

Eisai Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.98 1.29 1.09 0.94 0.84

Competitive Comparison of Eisai Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Eisai Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eisai Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eisai Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Eisai Co's Cyclically Adjusted PS Ratio falls into.



Eisai Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Eisai Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=6640.00/7369.71
=0.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eisai Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Eisai Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=664.242/107.2000*107.2000
=664.242

Current CPI (Mar. 2024) = 107.2000.

Eisai Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1,860.011 98.000 2,034.624
201409 1,902.080 98.500 2,070.081
201412 1,946.841 97.900 2,131.781
201503 1,954.675 97.900 2,140.359
201506 1,944.710 98.400 2,118.627
201509 1,903.148 98.500 2,071.243
201512 2,107.831 98.100 2,303.359
201603 1,695.201 97.900 1,856.236
201606 1,914.475 98.100 2,092.066
201609 1,856.716 98.000 2,031.020
201612 1,945.610 98.400 2,119.608
201703 1,813.579 98.100 1,981.811
201706 1,981.022 98.500 2,155.996
201709 1,999.832 98.800 2,169.858
201712 2,160.774 99.400 2,330.332
201803 2,239.795 99.200 2,420.424
201806 2,139.384 99.200 2,311.915
201809 2,188.587 99.900 2,348.514
201812 2,192.321 99.700 2,357.240
201903 2,447.327 99.700 2,631.429
201906 2,148.661 99.800 2,307.981
201909 2,027.298 100.100 2,171.092
201912 2,606.572 100.500 2,780.343
202003 2,920.723 100.300 3,121.650
202006 2,309.934 99.900 2,478.728
202009 2,113.046 99.900 2,267.453
202012 2,529.129 99.300 2,730.339
202103 2,059.263 99.900 2,209.740
202106 693.818 99.500 747.510
202109 2,280.304 100.100 2,442.044
202112 708.044 100.100 758.265
202203 665.847 101.100 706.022
202206 642.487 101.800 676.568
202209 607.928 103.100 632.104
202212 654.028 104.100 673.504
202303 691.077 104.400 709.612
202306 686.850 105.200 699.908
202309 615.832 106.200 621.631
202312 619.535 106.800 621.855
202403 664.242 107.200 664.242

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Eisai Co  (TSE:4523) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Eisai Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Eisai Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Eisai Co (TSE:4523) Business Description

Traded in Other Exchanges
Address
4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.

Eisai Co (TSE:4523) Headlines

No Headlines